Super Bowl Spreads Shift to Salads as Weight-Loss Drugs Gain Popularity

Food companies race to adapt to changing consumer preferences driven by GLP-1 appetite suppressants.

Published on Feb. 8, 2026

Got story updates? Submit your updates here. ›

As more Americans gain access to cheaper weight-loss medications like GLP-1 drugs, food companies are adjusting their offerings to cater to consumers focused on healthier, lower-calorie options. Marla Senzon and her husband, who used to indulge in high-calorie Super Bowl snacks, will now be enjoying salads while watching the game. Food brands are responding by adding more protein-rich, fiber-filled menu items, reducing portion sizes, and promoting healthier snack alternatives.

Why it matters

The rise of GLP-1 weight-loss drugs is driving a significant shift in consumer eating habits, forcing food companies to rethink their product lineups and marketing strategies to stay relevant. This trend could have long-lasting impacts on the food industry, as brands navigate balancing consumer demand for indulgent treats with the growing preference for healthier, lower-calorie options.

The details

Roughly 12% of Americans are now on GLP-1 appetite-suppressing medications, leading to a 4-6% reduction in grocery spending and 4-5% less spending on fast food. Food companies are responding by adding more protein-focused, fiber-rich menu items, reducing portion sizes, and promoting healthier snack alternatives. Brands like Chipotle, PepsiCo, and HelloFresh have all introduced GLP-1-friendly products and recipes to cater to this growing consumer segment.

  • The Super Bowl will take place on Sunday, February 9, 2026.
  • Marla Senzon and her husband began taking GLP-1 weight-loss medication two years ago.

The players

Marla Senzon

A Florida retiree who, along with her husband, has changed her Super Bowl snacking habits since starting a GLP-1 weight-loss medication two years ago.

Ryan Zink

The CEO of Colorado-based Good Times Restaurants, which recently added a protein bowl to its menu to cater to GLP-1 users.

Ramon Laguarta

The CEO of PepsiCo, who mentioned GLP-1 trends for the first time in two years during the company's earnings call, stating they would try to capitalize on the trend with smaller portions and more fiber and protein products.

Michelle Korsmo

The CEO of the National Restaurant Association, who stated that GLP-1 trends are on the minds of restaurant operators, leading to adjustments in portion sizes.

Ali Furman

A consumer consultant at PwC, who stated that GLP-1 users consume roughly 40% fewer calories, translating to 4-6% smaller grocery baskets and 4-5% less spending on fast food.

Got photos? Submit your photos here. ›

What they’re saying

“Everything about our eating habits has changed. I can see myself doing it forever.”

— Marla Senzon

“We view the GLP-1 trend as somewhat more long-lived and more than just a short-term fad.”

— Ryan Zink, CEO, Good Times Restaurants

“There's no question GLP-1s are on the mind of restaurant operators.”

— Michelle Korsmo, CEO, National Restaurant Association

“Rising GLP-1 use creates a real opportunity for food companies. Many GLP-1 users are willing to spend more than non-users on foods and supplements and even trade up in products like protein shakes when brands can clearly explain the health benefits.”

— Zak Stambor, Senior Analyst in Retail and Ecommerce, eMarketer

What’s next

Food companies are expected to continue introducing more GLP-1-friendly menu items and product offerings in the coming years as the popularity of these weight-loss medications continues to grow.

The takeaway

The rise of GLP-1 weight-loss drugs is driving a significant shift in consumer eating habits, forcing the food industry to adapt by offering healthier, lower-calorie options. This trend could have long-lasting impacts on the industry as brands balance indulgent treats with the growing preference for nutritious, protein-rich alternatives.